News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
Glenn J. Hanna explains why HPV vaccination = cancer prevention at ASCO
Photo of Glenn J. Hanna from dana-farber.org
Jun 2, 2024, 12:00

Glenn J. Hanna explains why HPV vaccination = cancer prevention at ASCO

ASCO shared on X/Twitter:

“ASCO24 study suggests the HPV vaccine is effective in preventing the development of several types of cancers caused by HPV, most particularly head and neck cancer in males. Glenn J. Hanna explains why HPV vaccination = cancer prevention.

See the science.”

Video attached to the post.
Source: ASCO/X

ASCO ASCO24 cancer cancers caused by HPV Glenn J. Hanna Head and Neck Cancer HPV vaccine OncoDaily Oncology
Insight
Jun 29, 2024, 23:21
Andrea Morandi: A critical vulnerability in triple-negative breast cancer
Blog
Jun 29, 2024, 23:07
Richi Childhood Cancer Foundation launches a new series Faces of Hope at the Richi House
Blog
Jun 29, 2024, 22:54
Caitlin Delaney: The reality of living with a rare cancer
Blog
Jun 29, 2024, 22:45
Improve your digital skills for better patient care with transition - European Cancer Organisation
Blog
Jun 29, 2024, 22:31
Novocure is looking for Regional Business Director, US CNS (Northeast)
Blog
Jun 29, 2024, 18:30
Anil D'Cruz: Need government legislation to decrease tobacco consumption
Blog
Jun 29, 2024, 17:42
Fantastic updates about treating intermediate-risk neuroblastoma - St. Baldrick’s Foundation
Insight
Jun 29, 2024, 16:57
MD Anderson Research Highlights: EHA 2024 Special Edition
Blog
Jun 29, 2024, 16:49
ESMO - IARC webinar on Epidemiological and Clinical Research on Cancer Survival and Outcome
Blog
Jun 29, 2024, 16:41
Mandy Lauw: Mentorship speed dating and kick-start of the Cancer Institute mentorship program
Insight
Jun 29, 2024, 16:24
Anand Patel: Highlighting challenges in MPNs at SOHO 2024
Blog
Jun 29, 2024, 16:09
Daniel Stover: Real world studies versus negative clinical trials